- Module 3 Overview
Management of Cirrhosis-Related Complications
- 0%Lesson 1
Diagnosis and Management of AscitesActivities
- 0%Lesson 2
Recognition and Management of Spontaneous Bacterial PeritonitisActivities
- 2A.Core Concepts
- 2B.Recognition and Management of SBP
- 2C.Role of Albumin in Treatment of SBP
- Lesson 2 Quiz/CME/CNE
- 0%Lesson 3
Screening for Varices and Prevention of BleedingActivities
- 3A.Core Concepts
- 3B.Screening for Varices and Prevention of Bleeding
- 3C.Portal Hypertension and Approach to Gastric Varices
- Lesson 3 Quiz/CME/CNE
- 0%Lesson 4
Diagnosis and Management of Hepatic EncephalopathyActivities
- 4A.Core Concepts
- 4B.Hepatic Encephalopathy
- 4C.Rifaximin Therapy for Hepatic Encephalopathy
- Lesson 4 Quiz/CME/CNE
- 0%Lesson 5
Referral for Liver Transplantation
- Module 3 Self-Assessment
Lesson 3 CE Quiz: Screening for Varices and Prevention of Bleeding
InstructionsChoose the single best answer for the following questions. You must answer all of the questions before you can check the answers.
You must answer all of the questions before submitting them.
1. Which one of the following best describes the patient group for whom screening esophagogastroduodenoscopy (EGD) is recommended to evaluate for the presence of gastroesophageal varices?
2. A 54-year-old woman undergoes upper endoscopy and esophageal varices are visualized. Which one of the following defines large varices?
3. A patient with cirrhosis has laboratory studies performed and undergoes screening upper endoscopy. What findings would indicate a need for primary prophylaxis against variceal hemorrhage?
4. Which one of the following oral regimens is recommended as a preferred pharmacologic medication for primary prophylaxis against variceal hemorrhage?
5. Which one of the following most accurately describes the impact of placement of a transjugular intrahepatic portosystemic shunt (TIPS) in a patient with cirrhosis who has experienced an episode of esophageal variceal bleeding?Sign In Required for CE. Please sign in to track your progress for continuing education credits.
Share by e-mailThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your undestanding of key concepts.
You must be signed in to customize your interaction with these questions.
- 0%Lesson 2
- HCV Medications
- Daclatasvir Daklinza
- Elbasvir-Grazoprevir Zepatier
- Ledipasvir-Sofosbuvir Harvoni
- Ombitasvir-Paritaprevir-Ritonavir Technivie
- Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir Viekira Pak
- Peginterferon alfa-2a Pegasys
- Peginterferon alfa-2b PegIntron
- Ribavirin Copegus, Rebetol, Ribasphere
- Simeprevir Olysio
- Sofosbuvir Sovaldi
- Sofosbuvir-Velpatasvir Epclusa
- Boceprevir Victrelis
- Telaprevir Incivek
- Course Modules
- Screening and Diagnosis of Hepatitis C Infection
- Evaluation, Staging, and Monitoring of Chronic Hepatitis C
- Management of Cirrhosis-Related Complications
- Evaluation and Preparation for Hepatitis C Treatment
- Treatment of Chronic Hepatitis C Infection
- Treatment of Special Populations and Special Situations
- Special Topics
- Slide LecturesCore ConceptsMaster Bibliography
ContributorsSite OverviewContent Bundles
- Clinical Calculators
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.